190 related articles for article (PubMed ID: 17441928)
1. Active and passive immunotherapy: vaccines and antibodies.
Oosterwijk E; Divgi C; Bander NH
BJU Int; 2007 May; 99(5 Pt B):1301-4. PubMed ID: 17441928
[No Abstract] [Full Text] [Related]
2. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
Bellmunt J; Ribas A
Eur Urol; 2009 Jun; 55(6):1342-3. PubMed ID: 19201525
[No Abstract] [Full Text] [Related]
3. Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
Clark PE
Eur Urol; 2009 Jun; 55(6):1343-4. PubMed ID: 19201523
[No Abstract] [Full Text] [Related]
4. Immunotherapy of surgical malignancies.
Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
[No Abstract] [Full Text] [Related]
5. Systemic treatment for renal cell carcinoma: an overview.
Swanson DA
Prog Clin Biol Res; 1990; 350():201-25. PubMed ID: 2201044
[No Abstract] [Full Text] [Related]
6. Adjuvant immunotherapy in colorectal cancer.
Vermorken JB
Semin Oncol; 2000 Oct; 27(5 Suppl 10):66-71. PubMed ID: 11049049
[No Abstract] [Full Text] [Related]
7. Tumor escape from the immune response: a major hurdle for successful immunotherapy of cancer?
Chouaib S
Tunis Med; 2005 Dec; 83 Suppl 12():7-10. PubMed ID: 16430055
[No Abstract] [Full Text] [Related]
8. Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ
Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutic approaches for the treatment of malignant melanoma.
Curiel-Lewandrowski C; Atkins MB
Curr Opin Investig Drugs; 2001 Nov; 2(11):1553-63. PubMed ID: 11763157
[TBL] [Abstract][Full Text] [Related]
10. [The role of immunotherapy in the treatment of patients with hematologic neoplasms].
Rukavitsyn OA
Vopr Onkol; 2002; 48(2):186-92. PubMed ID: 12227066
[No Abstract] [Full Text] [Related]
11. Renal cell carcinoma: recent progress and future directions.
Mulders P; Figlin R; deKernion JB; Wiltrout R; Linehan M; Parkinson D; deWolf W; Belldegrun A
Cancer Res; 1997 Nov; 57(22):5189-95. PubMed ID: 9371523
[No Abstract] [Full Text] [Related]
12. Specific antitumour vaccine for renal cancer.
Fishman M; Antonia S
Lancet; 2004 Feb; 363(9409):583-4. PubMed ID: 14987879
[No Abstract] [Full Text] [Related]
13. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy].
Horwacik I
Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040
[TBL] [Abstract][Full Text] [Related]
14. Vaccine therapy for renal cancer.
Amato RJ
Expert Rev Vaccines; 2008 Sep; 7(7):925-35. PubMed ID: 18767943
[TBL] [Abstract][Full Text] [Related]
15. Vaccines in lymphoma.
Levy R
Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
[No Abstract] [Full Text] [Related]
16. New approaches to immunoprevention and immunotherapy of neoplasms.
Glushkov AN
Russ J Immunol; 2002 Oct; 7(3):219-28. PubMed ID: 12674931
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic developments in renal cell cancer.
Prenen H; Gil T; Awada A
Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
[TBL] [Abstract][Full Text] [Related]
18. Vaccine therapy in patients with renal cell carcinoma.
Van Poppel H; Joniau S; Van Gool SW
Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapies in Early and Advanced Renal Cell Cancer.
Kasenda B; Larkin J; Gore M
Prog Tumor Res; 2015; 42():1-10. PubMed ID: 26376844
[TBL] [Abstract][Full Text] [Related]
20. Are vaccines making a comeback in non-small-cell lung cancer?
Nemunaitis JJ
J Clin Oncol; 2008 Mar; 26(9):1402-3. PubMed ID: 18349390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
